No NHI reimbursable for unauthorized indications.

In line with an NHI financial stabilization measure the MOHW is going to reject the NHI reimbursement for the medication for unauthorized indications, taking effect from coming April.

So far the government restrained the reimbursement rejection against medications for other indications than those approved in the product registration in view of calming down physicians complaints against the m...